IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Decibel Therapeutics Inc

CUSIP: 24343R106 | 90 institutional holders

Quarters

Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2023

Atlas Capital Advisors Inc.40,000
0.0% of portfolio›$36.4K
StyleTurnoverLocationFiled
Atlas Capital Advisors Inc.
40,000$36.4K0.0%ValueMediumJackson, WY2024-02-15